Antiretroviral Treatment Failure and Associated Factors Among HIV-Infected Children on Antiretroviral Therapy: A Retrospective Study

References

• Kharsany AB, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10(1):34. doi:10.2174/1874613601610010034
   PubMedGoogle Scholar
• HIV/AIDS JUNPo. Global HIV & AIDS statistics—2020 fact sheet; 2020. Available from: www.unaidsorg/en/resources/fact-sheet. Accessed February 12, 2021.
   Google Scholar
• Harries AD, Suthar AB, Takarinda KC, et al. Ending the HIV/AIDS epidemic in low-and middle-income countries by 2030: is it possible? F1000Research. 2016;5:2328. doi:10.12688/f1000research.9247.1
   Google Scholar
• UNAIDS. Ethiopian-UNSAIDS. 2019. Available from: https://www.unsaids.org/en/regionscountries/countries/ethiopia. accessed on date 22/09/2020.
   Google Scholar
• Blanco J, Clotet B. Learning from drug changes in antiretroviral therapy. Aids. 2013;27(5):833–834. doi:10.1097/QAD.0b013e32835c1213
   Web of Science ®Google Scholar
• Organization WH. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2016.
   Google Scholar
• Aldous JL, Haubrich RH. Defining treatment failure in resource-rich settings. Curr Opin HIV AIDS. 2009;4(6):459. doi:10.1097/COH.0b013e328331dea5
   PubMed Web of Science ®Google Scholar
• Ayele G, Tessema B, Amsalu A, Ferede G, Yismaw G. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia. BMC Immunol. 2018;19(1):37. doi:10.1186/s12865-018-0278-4
   PubMed Web of Science ®Google Scholar
• Health FMo. National Guidelines for Comprehensive HIV Prevention, Care and Treatment. USAID; 2017.
   Google Scholar
• Ayalew MB, Kumilachew D, Belay A, et al. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV/AIDS. 2016;8:141.
   Google Scholar
• Feleke R, Geda B, Teji Roba K, Weldegebreal F. Magnitude of antiretroviral treatment failure and associated factors among adult HIV-positive patients in Harar public hospitals, Eastern Ethiopia. SAGE Open Med. 2020;8:2050312120906076. doi:10.1177/2050312120906076
   Web of Science ®Google Scholar
• Bernheimer JM, Patten G, Makeleni T, et al. Paediatric HIV treatment failure: a silent epidemic. J Int AIDS Soc. 2015;18(1):20090. doi:10.7448/IAS.18.1.20090
   PubMed Web of Science ®Google Scholar
• Endalamaw A, Mekonnen M, Geremew D, Yehualashet FA, Tesera H, Habtewold TD. HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis. BMC Public Health. 2020;20(1):82. doi:10.1186/s12889-020-8160-8
   Web of Science ®Google Scholar
• Yihun BA, Kibret GD, Leshargie CT. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: a retrospective study. PLoS One. 2019;14(5):e0215300. doi:10.1371/journal.pone.0215300
   Web of Science ®Google Scholar
• Ethiopia F. National Guidelines for Comprehensive HIV Prevention, Care and Treatment. AAMo Health; 2017.
   Google Scholar
• Mekonnen E, Workicho A, Hussein N, Feyera T. Reasons and predictors for antiretroviral therapy change among HIV-infected adults at South West Ethiopia. BMC Res Notes. 2018;11(1):1–6. doi:10.1186/s13104-018-3470-y
   Google Scholar
• Ethiopia MoHFDRo. National Guidelines for Comprehensive HIV Prevention, Care and Treatment. Ethiopia MoHFDRo; 2014.
   Google Scholar
• Feola D, Thornton A, Garvy B. Effects of antiretroviral therapy on immunity in patients infected with HIV. Curr Pharm Des. 2006;12(9):1015–1022. doi:10.2174/138161206776055886
   Web of Science ®Google Scholar
• Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC Infect Dis. 2012;12(1):197.
   Web of Science ®Google Scholar
• Workneh N, Girma T, Woldie M, Michael KW, Lindstrom D. Immunologic and clinical outcomes of children on HAART: a Retrospective cohort analysis at Jimma University specialized hospital. Ethiop J Health Sci. 2009;19(2):2. doi:10.4314/ejhs.v19i2.69419
   Google Scholar
• Assemie MA, Alene M, Ketema DB, Mulatu S. Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: a systematic review and meta-analysis. Global Health Res Policy. 2019;4(1):1–10. doi:10.1186/s41256-019-0120-4
   Google Scholar
• Zeleke A. Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University Hospital, retrospective cohort study. Int J Med Med Sci. 2016;8(11):125–132. doi:10.5897/IJMMS2015.1164
   Google Scholar
• Haile GS, Berha AB. Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia. BMC Pediatr. 2019;19(1):37. doi:10.1186/s12887-019-1402-1
   Web of Science ®Google Scholar
• Yassin S, Gebretekle GB. Magnitude and predictors of antiretroviral treatment failure among HIV‐infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study. Pharmacol Res Perspect. 2017;5(1):e00296. doi:10.1002/prp2.296
   Web of Science ®Google Scholar
• Kukoyi O, Renner L, Powell J, et al. Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana. BMC Infect Dis. 2015;16(1):58. doi:10.1186/s12879-016-1402-9
   Web of Science ®Google Scholar
• Mgelea EM, Kisenge R, Aboud S. Detecting virological failure in HIV-infected Tanzanian children. S Afr Med j. 2014;104(10):696–699. doi:10.7196/SAMJ.7807
   Web of Science ®Google Scholar
• Costenaro P, Penazzato M, Lundin R, et al. Predictors of treatment failure in HIV-positive children receiving combination antiretroviral therapy: cohort data from Mozambique and Uganda. J Pediatric Infect Dis Soc. 2015;4(1):39–48. doi:10.1093/jpids/piu032
   Web of Science ®Google Scholar
• Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC Infect Dis. 2012;12(1):1–8. doi:10.1186/1471-2334-12-197
   PubMed Web of Science ®Google Scholar
• Davies M-A, Moultrie H, Eley B, et al. Virologic failure and second-line antiretroviral therapy in children in South Africa-The IeDEA Southern Africa Collaboration. J Acquired Immune Deficiency Syndromes. 2011;56(3):270. doi:10.1097/QAI.0b013e3182060610
   PubMed Web of Science ®Google Scholar
• Buck WC, Kabue MM, Kazembe PN, Kline MW. Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children. J Int AIDS Soc. 2010;13(1):31. doi:10.1186/1758-2652-13-31
   Web of Science ®Google Scholar
• Osman FT, Yizengaw MA. Virological failure and associated risk factors among HIV/AIDS pediatric patients at the ART clinic of Jimma University Medical Center, Southwest Ethiopia. Open AIDS J. 2020;14(1):1. doi:10.2174/1874613602014010061
   Google Scholar
• Rebouças MC, MOd S, Haguihara T, Brites C, Martins Netto E. Tuberculosis incidence among people living with HIV/AIDS with virological failure of antiretroviral therapy in Salvador, Bahia, Brazil. Br J Inf Dis. 2017;21(5):562–566. doi:10.1016/j.bjid.2017.05.005
   Web of Science ®Google Scholar
• Kumar P. Adult pulmonary tuberculosis as a pathological manifestation of hyperactive antimycobacterial immune response. Clin Transl Med. 2016;5(1):1–7. doi:10.1186/s40169-016-0119-0
   Google Scholar
• Cissé A-M, Laborde-Balen G, Kébé-Fall K, et al. High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal. BMC Pediatr. 2019;19(1):47. doi:10.1186/s12887-019-1420-z
   Web of Science ®Google Scholar
• Kamya MR, Mayanja-Kizza H, Kambugu A, et al. Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. JAIDS J Acquired Immune Deficiency Syndromes. 2007;46(2):187–193. doi:10.1097/QAI.0b013e31814278c0
   PubMed Web of Science ®Google Scholar
• Penot P, Héma A, Bado G, et al. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso. J Int AIDS Soc. 2014;17(1):18646. doi:10.7448/IAS.17.1.18646
   Web of Science ®Google Scholar
• Nega J, Taye S, Million Y, Rodrigo C, Eshetie S. Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia. AIDS Res Ther. 2020;17(1):1–9. doi:10.1186/s12981-020-00294-z
   PubMed Web of Science ®Google Scholar
• Misganie YG, Yizengaw A, Likie A, et al. Rate and predictors of treatment failure among pediatric population taking highly active antiretroviral therapy in Ethiopia. medRxiv. 2019;19005538.
   Google Scholar
• Prabhakar B, Banu A, Pavithra H, Chandrashekhara P, Sasthri S. Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy. Indian j Sexually Transmitted Dis AIDS. 2011;32(2):94. doi:10.4103/0253-7184.85412
   Google Scholar
• Martinez-Picado J, Deeks SG, Persistent HIV-1. replication during antiretroviral therapy. Curr Opin HIV AIDS. 2016;11(4):417. doi:10.1097/COH.0000000000000287
   PubMed Web of Science ®Google Scholar
• Liégeois F, Vella C, Eymard‐Duvernay S, et al. Virological failure rates and HIV‐1 drug resistance patterns in patients on first‐line antiretroviral treatment in semirural and rural Gabon. J Int AIDS Soc. 2012;15(2):17985. doi:10.7448/IAS.15.2.17985
   Web of Science ®Google Scholar
• Sibhat M, Kassa M, Gebrehiwot H. Incidence and predictors of treatment failure among children receiving first-line antiretroviral treatment in general hospitals of two zones, Tigray, Ethiopia, 2019. Pediatr Health Med Ther. 2020;11:85. doi:10.2147/PHMT.S243656
   Web of Science ®Google Scholar
• Emmett SD, Cunningham CK, Mmbaga BT, et al. Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J Acquir Immune Defic Syndr. 2010;54(4):368. doi:10.1097/QAI.0b013e3181cf4882
   PubMed Web of Science ®Google Scholar
• Sebunya R, Musiime V, Kitaka SB, Ndeezi G. Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic. AIDS Res Ther. 2013;10(1):1–10. doi:10.1186/1742-6405-10-25
   Web of Science ®Google Scholar